ARAGON PHARMACEUTICALS
Aragon Pharmaceuticals is a discovery-stage small molecule company focused on therapeutics for the treatment of hormone-resistant cancers, with an initial focus on prostate and breast cancer.
ARAGON PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.aragonpharmaceuticals.com
Total Employee:
11+
Status:
Active
Contact:
858-369-7600
Email Addresses:
[email protected]
Total Funding:
122 M USD
Technology used in webpage:
U.S. Server Location
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Inception Sciences
Inception Sciences creates therapies with transformative potential to address diseases and disorders with significant unmet need.
Innovus Pharmaceuticals
Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.
Lumena Pharmaceuticals
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
Provectus Biopharmaceuticals
Provectus Biopharmaceuticals is investigating new therapies for the treatment of skin cancer, liver cancer and breast cancer.
Tioga Pharmaceuticals
Tioga Pharmaceuticals develops therapies for the treatment of gastrointestinal diseases.
VitaCare
VitaCare is a healthcare services platform that helps patients navigate access to brand medications.
ZS Pharma
ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
The Column Group
The Column Group investment in Series D - Aragon Pharmaceuticals
OrbiMed
OrbiMed investment in Series D - Aragon Pharmaceuticals
venBio Partners
venBio Partners investment in Series D - Aragon Pharmaceuticals
Aisling Capital
Aisling Capital investment in Series D - Aragon Pharmaceuticals
Topspin Partners
Topspin Partners investment in Series C - Aragon Pharmaceuticals
The Column Group
The Column Group investment in Series B - Aragon Pharmaceuticals
Aisling Capital
Aisling Capital investment in Series B - Aragon Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Aragon Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Aragon Pharmaceuticals
The Column Group
The Column Group investment in Series A - Aragon Pharmaceuticals
Official Site Inspections
http://www.aragonpharmaceuticals.com
- Host name: 148.177.10.9
- IP address: 148.177.10.9
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aragon Pharmaceuticals"
Aragon Pharmaceuticals, Inc. (Acquired by Johnson & Johnson)
Similar Companies: LifeCanvas Technologies USA n/a LifeCanvas Technologies is a multidisciplinary team of experts in neuroscience, cancer, computational biology, machine …See details»
Aragon Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical …
Explore Aragon Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 22 clinical trials, 9 news, and 12 literature, Disease Domain:Neoplasms, Technology …See details»
Aragon Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Aragon Pharmaceuticals, Inc. of Los Angeles, CA. Get the latest business insights from Dun & …See details»
Johnson & Johnson Completes Acquisition Of Aragon …
New Brunswick, NJ (August 19, 2013) -- Johnson & Johnson (NYSE: JNJ) today announced it has successfully completed its acquisition of Aragon Pharmaceuticals, Inc., a privately-held …See details»
Aragon Pharmaceuticals - PitchBook
Aragon Pharmaceuticals General Information Description. Developer of anti-endocrine therapies intended for the biology of hormone-resistant cancers. The company focuses on nuclear receptor biology, medicinal chemistry, and drug …See details»
Aragon Pharmaceuticals - Products, Competitors, Financials, …
Jan 17, 2019 Headquarters Location. 12780 El Camino Real Suite 301. San Diego, California, 92130, United States. 858-334-4830See details»
Aragon Pharmaceuticals - Funding, Financials, Valuation & Investors
Aragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer. Search Crunchbase. Start Free Trial . ... How much …See details»
Aragon Pharmaceuticals - VentureRadar
In addition, Aragon Pharmaceuticals has a selective estrogen receptor degrader (SERD) for hormone-sensitive and hormone-resistant estrogen receptor positive breast cancer targeted to …See details»
Aragon Pharmaceuticals - Golden
Organization. Company attributes. Industry. Technology. Biology. Healthcare. Biotechnology. Location. San Diego. AngelList URL. angel.co/aragon-pha...maceuticals. ... Find more …See details»
Aragon Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Aragon Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Employee Profiles 1. Number of Board Member and Advisor …See details»
Aragon Pharmaceuticals, Inc. (Aragon Pharmaceuticals, Inc.) - 药物 …
了解Aragon Pharmaceuticals, Inc. (Aragon Pharmaceuticals, Inc.)公司的药物管线，治疗领域，技术平台，以及它的22项临床试验, 14篇新闻和3篇文献，疾病领域:肿瘤，技术平台:小分子化 …See details»
Aragon Pharmaceuticals, Inc. Announces Closing of Its Acquisition …
Aug 19, 2013 Aragon Pharmaceuticals, Inc. , a leader in developing drugs for hormone-driven cancers, today announced the closing of its acquisition by Johnson & Johnson. Deal terms …See details»
J&J announces $1bn deal to acquire Aragon Pharma
Jun 17, 2013 Johnson & Johnson is to acquire cancer-focused company, Aragon Pharmaceuticals, in a definitive agreement worth up to US $1 billion. Aragon is a discovery …See details»
Aragon Pharmaceuticals Announces Acquisition by Johnson
Jun 19, 2013 Aragon Pharmaceuticals Inc. has announced a definitive agreement with Johnson & Johnson whereby Aragon will be acquired for $650 million in cash up front along with $350 …See details»
Aragon Pharmaceuticals to be Acquired for $1 Billion
Aragon Pharmaceuticals Inc. recently announced a definitive agreement with Johnson & Johnson whereby Aragon will be acquired for $650 million in cash up front along with $350 million in …See details»
Aragon
At Farm Tray We understand the need to source and supply high quality products to its customers especially when dealing with food ingredients Sourcing is done from ISO 9001 and HACCP …See details»
Aragon Pharmaceuticals Announces $8 Million Series A Financing
LA JOLLA, Calif., May 20 /PRNewswire/ -- Aragon Pharmaceuticals today announced it has raised $8 million in Series A financing led by The Column Group and OrbiMed Advisors. Funds …See details»
J&J snags another promising prostate cancer drug in ... - Fierce …
Jun 17, 2013 Aragon's big cancer drug--ARN-509--was built around the idea that if you can build a better anti-androgen drug, you can offer new hope to castration-resistant prostate cancer …See details»
Seragon | About Seragon
Seragon is a global biotech company optimizing human health and longevity around the world with a progressive approach to biomedical design. We’re spearheading the next exciting …See details»